Status:
UNKNOWN
Evaluation of Eosinophil Phenotype in COPD Patients
Lead Sponsor:
IRCCS San Raffaele Roma
Conditions:
COPD
COPD Exacerbation
Eligibility:
All Genders
18+ years
Brief Summary
This is a pilot non pharmacological observational study. Aim of the study is to analyze the immunophenotype of circulating eosinophils in chronic obstructive pulmonary disease (COPD) patients, and to ...
Detailed Description
In about 30% of COPD patients there is an increased number of circulating eosinophils. On their membrane, eosinophils express several molecules, also related to their physiology, namely major histocom...
Eligibility Criteria
Inclusion
- COPD
- percentage of eosinophils \>0%
- episode of exacerbation in the previous 10 days (for exacerbated cohort)
- no exacerbation in the previous 3 months (for stable cohort)
Exclusion
- percentage of eosinophils =0%
- history of allergic diseases
- patients that are currently enrolled in other clinical trials involving new drugs or treatments
Key Trial Info
Start Date :
March 19 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04494308
Start Date
March 19 2019
End Date
July 1 2025
Last Update
April 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS San Raffaele Pisana
Roma, RM, Italy, 00166